日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

STHELAR, a multi-tissue dataset linking spatial transcriptomics and histology for cell type annotation

STHELAR 是一个多组织数据集,它将空间转录组学和组织学联系起来,用于细胞类型注释。

Giraud-Sauveur, Félicie; Blampey, Quentin; Benkirane, Hakim; Marinello, Arianna; Cournède, Paul-Henry; Christodoulidis, Stergios

Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung Cancer

RET阳性非小细胞肺癌中膜靶点的表达及其在治疗中的作用

Marinello, Arianna; Ghigna, Maria Rosa; Rotow, Julia K; Adeyelu, Tolulope; Metro, Giulio; Brandão, Mariana; Guisier, Florian; Monnet, Isabelle; Gaultier de Saint Basile, Hortense; Genova, Carlo; Raimbourg, Judith; Terrisse, Safae; Godefroy, Karine; Toschi, Luca; Mandarano, Martina; Doubre, Hélène; Russo, Alessandro; Valent, Alexander; Naqash, Abdul Rafeh; Aijaz, Ayesha; Gazzah, Anas; Remon, Jordi; Vanderwalde, Ari; Elliott, Andrew; Halmos, Balazs; Barlesi, Fabrice; Planchard, David; Jänne, Pasi A; Besse, Benjamin; Aldea, Mihaela

AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors.

AP1 介导的 EGFR 表达重编程可导致 RET 重排肿瘤对 BLU-667 和 LOXO-292 产生耐药性

Esposito Daniela, Ascione Claudia Maria, Belli Stefania, Napolitano Fabiana, Servetto Alberto, Pepe Felice, Malapelle Umberto, Iaccarino Antonino, Troncone Giancarlo, Barone Diletta, Bria Emilio, Ferrara Roberto, Lorenzini Daniele, Lo Russo Giuseppe, Ghigna Maria Rosa, Marinello Arianna, Aldea Mihaela, Besse Benjamin, Formisano Luigi, Bianco Roberto

Immune-checkpoint targeting drug conjugates: a novel class of promising therapeutic agents for cancer treatment

免疫检查点靶向药物偶联物:一类新型的、有前景的癌症治疗药物

Marchesi, Silvia; Marinello, Arianna; Ambrosini, Paolo; Cavalli, Chiara; Lo Russo, Giuseppe; Occhipinti, Mario

Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms

EGFR突变型非小细胞肺癌患者出现CCDC6-RET融合和BRAF V600E突变作为旁路耐药机制的个体化治疗

Marinello, Arianna; Parisi, Claudia; Vasseur, Damien; Combarel, David; Bihoreau, Juliette; Lavaud, Pernelle; Ezzedine, Rémy; Zullo, Lodovica; Friboulet, Luc; Zalcman, Gerard; Italiano, Antoine; Besse, Benjamin; Aldea, Mihaela

Prevalence of Thromboembolic Events in Patients With Non-Small Cell Lung Cancer and RET Fusions

非小细胞肺癌合并RET融合基因患者血栓栓塞事件的发生率

Aldea, Mihaela; Marinello, Arianna; Guyon, David; Gazzah, Anas; Barlesi, Fabrice; Planchard, David; Besse, Benjamin

A Case of Pulmonary Sarcoidosis during First-Line Targeted Therapy with Dabrafenib Plus Trametinib in BRAF V600E-Mutated Metastatic Melanoma

一例BRAF V600E突变转移性黑色素瘤患者接受达拉非尼联合曲美替尼一线靶向治疗期间发生肺结节病的病例报告

Tronconi, Maria Chiara; Marinello, Arianna; Solferino, Alessandra; Grimaudo, Susanna; Ciccarelli, Michele; Manara, Sofia; Cozzaglio, Luca; Mancini, Luca; Borroni, Riccardo; Santoro, Armando

Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab

接受辅助皮下注射曲妥珠单抗与静脉注射曲妥珠单抗治疗的HER2阳性早期乳腺癌患者心脏毒性的临床预测因素

De Sanctis, Rita; Giordano, Laura; D'Antonio, Federica; Agostinetto, Elisa; Marinello, Arianna; Guiducci, Daniela; Masci, Giovanna; Losurdo, Agnese; Zuradelli, Monica; Torrisi, Rosalba; Santoro, Armando

A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician's Choice in a New Therapeutic Scenario

乐伐替尼与索拉非尼一线治疗不可切除肝细胞癌的比较:指导医生在新治疗方案中做出选择的筛选标准

Dipasquale, Angelo; Marinello, Arianna; Santoro, Armando